NASDAQ:LQDA
Liquidia Technologies Inc. Stock Company Profile
$12.79
-0.190 (-1.46%)
At Close: May 03, 2024
Information
419 Davis Drive, Suite 100
Morrisville NC 27560
919 328 4400
www.liquidia.com
Industry: Biotechnology
Sector: Healthcare
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.